Keung AC - Search Results

1

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide.

Peloquin CA, Jaresko GS, Yong CL, Keung AC, Bulpitt AE, Jelliffe RW. Peloquin CA, et al. Among authors: keung ac. Antimicrob Agents Chemother. 1997 Dec;41(12):2670-9. doi: 10.1128/AAC.41.12.2670. Antimicrob Agents Chemother. 1997. PMID: 9420037 Free PMC article. Clinical Trial.

2

Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study.

Keung AC, Owens RC Jr, Eller MG, Weir SJ, Nicolau DP, Nightingale CH. Keung AC, et al. Antimicrob Agents Chemother. 1999 May;43(5):1230-3. doi: 10.1128/AAC.43.5.1230. Antimicrob Agents Chemother. 1999. PMID: 10223941 Free PMC article. Clinical Trial.

3

Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects.

Dimmitt DC, Cramer MB, Keung A, Arumugham T, Weir SJ. Dimmitt DC, et al. Cancer Chemother Pharmacol. 1999;43(2):126-32. doi: 10.1007/s002800050872. Cancer Chemother Pharmacol. 1999. PMID: 9923817 Clinical Trial.

4

Single-dose pharmacokinetics of rifapentine in women.

Keung AC, Eller MG, Weir SJ. Keung AC, et al. J Pharmacokinet Biopharm. 1998 Feb;26(1):75-85. doi: 10.1023/a:1023276808298. J Pharmacokinet Biopharm. 1998. PMID: 9773393

5

Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction.

Keung AC, Eller MG, Weir SJ. Keung AC, et al. J Clin Pharmacol. 1998 Jun;38(6):517-24. doi: 10.1002/j.1552-4604.1998.tb05789.x. J Clin Pharmacol. 1998. PMID: 9650541 Clinical Trial.

6

Single and multiple dose pharmacokinetics of rifapentine in man: part II.

Keung A, Eller MG, McKenzie KA, Weir SJ. Keung A, et al. Int J Tuberc Lung Dis. 1999 May;3(5):437-44. Int J Tuberc Lung Dis. 1999. PMID: 10331734 Clinical Trial.

7

The effect of food on the bioavailability of dolasetron mesylate tablets.

Lippert C, Keung A, Arumugham T, Eller M, Hahne W, Weir S. Lippert C, et al. Biopharm Drug Dispos. 1998 Jan;19(1):17-9. doi: 10.1002/(sici)1099-081x(199801)19:1<17::aid-bdd71>3.0.co;2-#. Biopharm Drug Dispos. 1998. PMID: 9510981 Clinical Trial.

8

Pharmacokinetics and safety of single intravenous and oral doses of dolasetron mesylate in healthy women.

Keung AC, Landriault H, Lefebvre M, Gossard D, Dempsey EE, Juneau M, Dimmitt D, Castles M, Roberts L, Spenard J. Keung AC, et al. Biopharm Drug Dispos. 1997 May;18(4):361-9. doi: 10.1002/(sici)1099-081x(199705)18:4<361::aid-bdd25>3.0.co;2-i. Biopharm Drug Dispos. 1997. PMID: 9158883 Clinical Trial.

9

Disposition and metabolism of 14C-rifapentine in healthy volunteers.

Reith K, Keung A, Toren PC, Cheng L, Eller MG, Weir SJ. Reith K, et al. Drug Metab Dispos. 1998 Aug;26(8):732-8. Drug Metab Dispos. 1998. PMID: 9698286

10

Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I.

Keung A, Reith K, Eller MG, McKenzie KA, Cheng L, Weir SJ. Keung A, et al. Int J Tuberc Lung Dis. 1999 May;3(5):426-36. Int J Tuberc Lung Dis. 1999. PMID: 10331733 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters